EDBI

EDBI, established in 1991, is a Singapore-based corporate venture capital arm of the Singapore Economic Development Board. The organization focuses on investing in high-growth sectors, particularly in information and communication technology, emerging technology, healthcare, and advanced manufacturing. As a government-backed entity, EDBI aims to support companies in achieving their growth ambitions by providing not only capital but also access to a broad network and resources. With a commitment to patient capital, EDBI assists businesses looking to expand in Asia and beyond, fostering innovation and development in strategic industries.

Alvin Chew

Managing Partner, Investments

Swee-Yeok Chu

CEO and President

Ang Jen Keng

Deputy Director, Corporate Finance, Corporate Communications and Digital Strategy

Eugene Khoo

Group Director Corporate Finance, Corporate Communications and Digital Strategy

Lawrence Low

Senior Vice President, Investments and China Head

Basil Lui

Senior Vice President of Investments and Head of Emerging Tech and Value Creation

Jeong Shing Ong

Partner, Investments

Jolene Ooi

Senior Principal

Chu Swee Yeok

Chief Executive Officer and President

Past deals in Singapore

Tessa Therapeutics

Series A in 2022
Tessa Therapeutics Pte Ltd. is a biotechnology company focused on developing innovative cancer immunotherapies, specifically targeting solid tumors. Founded in 2011 and based in Singapore, the company specializes in creating virus-specific T cells and CAR T cells aimed at treating lymphoma. By advancing these therapies, Tessa Therapeutics seeks to provide healthcare providers with effective options to improve the lives of cancer patients.

Neuron Mobility

Series B in 2022
Neuron Mobility Pte. Ltd. provides electric scooters and bicycles rental services around Singapore. The company was incorporated in 2016 and is based in Singapore.

Us2.ai

Series A in 2022
Us2.ai develops software and digital tools for echocardiography using artificial intelligence. It provides online solutions to simplify access of results of echo analysis and heart ultrasound. Us2.ai is based in Singapore.

Beam

Series B in 2022
Beam Mobility Holdings Pte. Ltd. is a Singapore-based company that specializes in the rental of electronic scooters. Established in 2018, Beam operates through a mobile application that facilitates the rental process for users. The company promotes responsible parking by incentivizing customers to return e-scooters to designated parking spots, thereby reducing street congestion and enhancing urban mobility. Beam aims to provide a convenient and eco-friendly transportation alternative for urban dwellers.

Mirxes

Series C in 2022
MiRXES Pte. Ltd. develops life science research tools and molecular diagnostic tests or research and clinical diagnostic use. It offers RT-qPCR assays, assay panels, spike-in RNA kits, and biomarker discovery solutions. The company was founded in 2014 and is based in Singapore.

Modalku

Series C in 2022
Modalku is an online marketplace based in Jakarta, Indonesia for small businesses to acquire loans and for lenders to fund small business loans to earn compelling returns. Its technology-based approach enables borrowers to receive loans for the first time or at lower than market rates, while lenders will earn returns well above that of bank deposits, traditional fixed income products, and life insurance investment-linked products. This marketplace lending model is proven in countries such as USA, UK, China & Singapore.

Funding Societies

Series C in 2022
Funding Societies Pte. Ltd. is a peer-to-peer financing platform based in Singapore, founded in 2015. It connects investors with small and medium-sized enterprises (SMEs) seeking funding, thereby addressing financial inclusion challenges and making credit-worthy SMEs more bankable. The platform offers a range of flexible financing options, including micro and term loans, as well as invoice financing, supported by advanced credit scoring and risk assessment models. Since its inception, Funding Societies has facilitated over 3.3 million business loans, amounting to more than S$1.8 billion in funding. The company has received multiple accolades, including the Global Excellence Award from ITU Telecom, and holds operating licenses from regulators in Singapore, Indonesia, and Malaysia, making it a pioneer in the region's peer-to-peer lending landscape.

Next Gen Foods

Series A in 2022
Next Gen Foods is a food-tech startup that offers plant-based meats products. We use plants to create a delicious and satisfying meat experience that will make you forget animal meat even exists.

Sleek

Series A in 2021
Sleek Tech Pte. Ltd. is a Singapore-based company that provides a range of services including incorporation, registration, company secretary, accounting, and work visas through an online platform. Established in 2017, Sleek aims to simplify the business setup process for startups, small and medium enterprises, venture capitalists, and entrepreneurs. The company offers 100% digital solutions for company incorporation and governance management, addressing frustrations with traditional, paper-based processes. With a focus on efficiency and technology, Sleek has incorporated hundreds of companies in Singapore and Hong Kong, enhancing the experience for clients navigating the complexities of business formation and compliance.

bolttech

Series A in 2021
Bolttech builds a digital ecosystem that offers a platform to create and provide digital insurance & device protection products & services.

ShopBack

Series E in 2021
ShopBack offers a one-stop lifestyle portal that powers smarter purchase decisions for consumers. Today, ShopBack is the dominant player in Southeast Asia’s e-commerce Cashback market, with an established presence in Singapore, Malaysia, Indonesia, the Philippines, Thailand, and Taiwan, powering over 1,000 orders per hour. ShopBack enhances shopping by providing up to 30% Cashback for consumers to boost their purchasing power while providing cost-effective marketing solutions for merchant partners. With over 1,300 merchant partners, including Uber, Expedia, and Lazada, ShopBack constantly strives to bring a smarter shopping experience to the consumers. In October 2015, ShopBack was awarded the winner of the Gold award in the Best Start-up (Growth Stage) category and Silver award in the Best Innovative Infocomm Products (Consumers) category at the 7th Singapore Infocomm Technology Federation (SiTF) Awards. This is the local start-up’s maiden voyage in industry awards, pitting against more than 300 nominations for the esteemed titles. The company was recently awarded the Emerging Enterprise Award in September 2016, jointly organized by The Business Times (Singapore) and OCBC Bank, which recognizes outstanding small and medium enterprises (SMEs) in Singapore.

bolttech

Series A in 2021
Bolttech builds a digital ecosystem that offers a platform to create and provide digital insurance & device protection products & services.

Neuroglee Therapeutics

Series A in 2021
Neuroglee Therapeutics Pte. Ltd. specializes in the discovery, development, and commercialization of a digital therapeutic platform aimed at patients with neurodegenerative diseases. Established in 2020 and based in Singapore, the company offers innovative digital therapeutics and monitoring tools, including NG-001, a software designed for the symptomatic treatment of Alzheimer's disease and mild cognitive impairment (MCI). This platform captures digital biomarkers and learns from user behavior to provide tailored therapeutic interventions. Neuroglee's software employs machine-learning algorithms to personalize therapy by automatically adjusting mobile-based activities based on various digital biomarkers related to cognitive function, mood, and behavior. The company also explores investigational prescription digital therapeutics that can complement traditional pharmacotherapy for neurodegenerative conditions.

Mirxes

Series C in 2021
MiRXES Pte. Ltd. develops life science research tools and molecular diagnostic tests or research and clinical diagnostic use. It offers RT-qPCR assays, assay panels, spike-in RNA kits, and biomarker discovery solutions. The company was founded in 2014 and is based in Singapore.

SCI Ecommerce

Venture Round in 2021
Provider of marketing services intended to help in planning and executing digital marketing campaigns. The company offers services that increase brand awareness and conversion rate, which drive sales on various platforms, enabling clients to navigate and manage the complex supply chain and earn more profits.

Nuevocor

Series A in 2021
Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased hearts.

Engine Biosciences

Series A in 2021
Engine Biosciences is a biotechnology company focused on drug discovery through the application of machine learning to genomics. Based in San Francisco and Singapore, the company has developed a proprietary platform that integrates high-throughput laboratory experimentation with artificial intelligence algorithms to analyze complex biological networks. This approach generates unique data on gene interactions and provides biological insights validated through controlled experiments. By deciphering the intricacies of genetic codes, Engine Biosciences aims to accelerate and reduce the costs of research and development for new medical therapies. The platform supports various applications, including target discovery, drug repositioning, and precision medicine, and is utilized by both the company's internal teams and its partners across a range of disease indications. Founded in 2014, the team includes members from prestigious institutions such as MIT, Harvard, and the Mayo Clinic.

Esco Lifesciences

Series A in 2021
Esco Lifesciences Group provides enabling technologies, products, and services for the life sciences and healthcare industries, supporting academic research and scientific discoveries, clinical practice, as well as biopharmaceutical R&D and manufacturing.

Hummingbird Bioscience

Series C in 2021
Hummingbird Bioscience Pte. Ltd. is a biotechnology company based in Singapore, specializing in the development of antibody-based therapeutics for cancer. Founded in 2014, it leverages advances in systems biology and a proprietary rational antibody discovery platform to create innovative biotherapeutics. The company focuses on a diverse pipeline of drug candidates, which includes lead assets such as HMBD-001, an anti-HER3 antibody, and HMBD-002, an anti-VISTA antibody, both aimed at addressing significant unmet medical needs in oncology. Hummingbird Bioscience has established strategic collaborations with notable organizations such as Cancer Research UK and Amgen, and it has received a product development grant from the Cancer Prevention and Research Institute of Texas. The company's goal is to enhance treatment options for patients facing challenging cancer diagnoses through its cutting-edge research and development efforts.

Neon

Private Equity Round in 2021
Cityneon Holdings Limited, founded in 1956 and based in Singapore, specializes in providing interior architecture and experiential environment services globally. The company caters to multinational corporations, governments, and private organizations by offering a wide range of services, including event management, logistics, and project consulting. Cityneon is involved in the design and installation of exhibitions, pavilions, and thematic environments, as well as the decoration of commercial spaces and museums. It also rents reusable modules and furnishings and engages in the production of environmental graphic materials for events. Additionally, the company has diversified into exhibition production based on popular franchises, such as Jurassic Park, and is involved in civil engineering and real estate activities. Over the years, Cityneon has evolved from its beginnings as a supplier of electrical appliances to a leader in creating immersive brand experiences.

ImmunoScape

Venture Round in 2021
ImmunoScape PTE. LTD. is a Singapore-based company that focuses on immunotherapy by identifying tumor antigen-specific T cells and conducting deep profiling of immune cells. Utilizing high-dimensional mass spectrometry methods, the company measures alterations in immune cells, particularly T cell specificity, to aid in biomarker and target identification. By providing insights from clinical trial patient data, ImmunoScape supports pharmaceutical and biotechnology companies in developing more effective immunotherapies. Additionally, the company is engaged in vaccine development. Founded in 2016, ImmunoScape leverages advanced technologies to enhance understanding of immune responses and improve therapeutic outcomes.

Vesta

Venture Round in 2020
Vesta Corporation specializes in electronic payment solutions, catering primarily to e-commerce and telecommunications industries globally. The company offers various merchant services, including vSafe for Small to Midsize Businesses, an effective payment and fraud protection solution for smaller digital goods merchants, and vSafe for Enterprise, which provides comprehensive payment management and fraud prevention for larger organizations. Additionally, Vesta's vGuaranteed service supports online retailers by minimizing fraud risk. The company also offers consumer lending solutions, such as DelayPay, which allows prepaid wireless customers to make installment payments for phone refills. Vesta emphasizes revenue growth for its partners by leveraging a real-time decisioning platform that utilizes data science and machine learning to evaluate the risk of online transactions. Founded in 1995 and headquartered in Lake Oswego, Oregon, Vesta operates globally with centers in the United States, Ireland, China, and an office in Singapore.
Transcelestial Technologies Pte. Ltd., established in 2016 and based in Singapore, focuses on developing a cutting-edge wireless communication network utilizing laser technology. This innovative system aims to deliver high-speed, long-distance point-to-point data transfer for both terrestrial and satellite applications. The proposed network is designed to operate at speeds up to 1000 times faster than existing solutions, offering enhanced performance and reliability. Additionally, the system is expected to be resilient against jamming and does not require spectrum pre-allocation or regulation, distinguishing it from traditional communication methods.

Doctor Anywhere

Series B in 2020
Doctor Anywhere is a Singapore-based telehealth company that provides on demand healthcare solutions to help you lead happier, healthier lives. Their digital platform gives you quick access to health and wellness solutions, wherever you are. Their platform makes healthcare simple, seamless and convenient, and is optimised to help you manage your health in a way that best suits your lifestyle needs. With technology, better health outcomes are more achievable than ever before. They recognize modern-day struggles and are dedicated to improving healthcare services to suit our evolving lifestyle preferences.

ShopBack

Series B in 2020
ShopBack offers a one-stop lifestyle portal that powers smarter purchase decisions for consumers. Today, ShopBack is the dominant player in Southeast Asia’s e-commerce Cashback market, with an established presence in Singapore, Malaysia, Indonesia, the Philippines, Thailand, and Taiwan, powering over 1,000 orders per hour. ShopBack enhances shopping by providing up to 30% Cashback for consumers to boost their purchasing power while providing cost-effective marketing solutions for merchant partners. With over 1,300 merchant partners, including Uber, Expedia, and Lazada, ShopBack constantly strives to bring a smarter shopping experience to the consumers. In October 2015, ShopBack was awarded the winner of the Gold award in the Best Start-up (Growth Stage) category and Silver award in the Best Innovative Infocomm Products (Consumers) category at the 7th Singapore Infocomm Technology Federation (SiTF) Awards. This is the local start-up’s maiden voyage in industry awards, pitting against more than 300 nominations for the esteemed titles. The company was recently awarded the Emerging Enterprise Award in September 2016, jointly organized by The Business Times (Singapore) and OCBC Bank, which recognizes outstanding small and medium enterprises (SMEs) in Singapore.

eko.ai

Funding Round in 2020
Eko.ai Pte. Ltd. is a Singapore-based company that specializes in artificial intelligence software aimed at the early detection and treatment of heart disease. Founded in 2017, the company focuses on democratizing echocardiography and ultrasound imaging to enhance cardiovascular risk assessment. Eko.ai employs machine learning to automate processes, providing research teams with fully classified, machine learning-ready databases and a variety of tools, including segmentation and validation models. By collaborating with clinician scientists, sonographers, and deep learning experts, Eko.ai serves laboratories worldwide, aiming to improve productivity and patient outcomes within hospital systems.

SWAT Mobility

Series A in 2019
SWAT Mobility’s vehicle-routing technology helps companies, transport operators and government agencies around the world solve complex transportation challenges. We are the first in Asia to run high-capacity vehicle pooling services that is both on-demand and dynamically-routed. We also have proven results in helping our clients reduce transportation costs, improve city connectivity and reduce traffic congestion woes. Our technology tops the industry Li & Lim's benchmark, and with our cutting-edge smart mobility optimisation engine, we are future-ready for the world of autonomous vehicles.

M-DAQ

Venture Round in 2019
M-DAQ Pte Ltd (formerly known as Summit Investment Pte Ltd) was founded by a group of veterans from the FX and Securities Industries with experience averaging 15 years amongst the key members. M-DAQ is an innovative and unique solution, providing a platform to price and trade any exchange-traded products in more than one currency by blending ‘executable’ FX rates into equities and futures products. M-DAQ is the IP owner and holds the key relationships with the National Exchanges and the Global FX Banks. M-DAQ handles the entire consultancy work for each Exchange to be enabled on M-DAQ Solution, and provides the Exchange and the FX Consortium Banks with a license to use the M-DAQ solution. In addition, the partner Exchange will receive a revenue share of the net FX margins. The Exchange partners continues to operate the new cross-currency platform under existing in-country regulatory framework.

Neon

Private Equity Round in 2019
Cityneon Holdings Limited, founded in 1956 and based in Singapore, specializes in providing interior architecture and experiential environment services globally. The company caters to multinational corporations, governments, and private organizations by offering a wide range of services, including event management, logistics, and project consulting. Cityneon is involved in the design and installation of exhibitions, pavilions, and thematic environments, as well as the decoration of commercial spaces and museums. It also rents reusable modules and furnishings and engages in the production of environmental graphic materials for events. Additionally, the company has diversified into exhibition production based on popular franchises, such as Jurassic Park, and is involved in civil engineering and real estate activities. Over the years, Cityneon has evolved from its beginnings as a supplier of electrical appliances to a leader in creating immersive brand experiences.

Struto

Series D in 2019
Structo Pte. Ltd., established in 2014 and based in Singapore, specializes in developing and manufacturing industrial-grade 3D printers and materials. The company utilizes proprietary liquid crystal dynamic mask stereolithography (MSLA) technology to produce high-speed 3D printing solutions, particularly for digital dentistry applications. Structo's innovations enable users to achieve higher throughput at reduced costs, all while maintaining exceptional print quality. Through its advanced technology, the company aims to transform dental business models by enhancing efficiency and effectiveness in the 3D printing process.

DataRobot

Series E in 2019
DataRobot, Inc. develops an automated machine learning platform designed to help enterprises build predictive models efficiently. The company's offerings include DataRobot Cloud, a predictive analytics platform available on-site or via the cloud, and DataRobot MLOps, which focuses on the deployment, monitoring, and management of machine learning models within organizations. Additionally, DataRobot Enterprise provides features such as flexible deployment, governance, and support, along with packages aimed at accelerating artificial intelligence projects and education services. The platform is suitable for a diverse range of professionals, including business analysts, data scientists, and IT specialists across various industries like banking, healthcare, and marketing. Founded in 2012 and headquartered in Boston, Massachusetts, DataRobot also maintains operations in several international locations, including London, Paris, Kyiv, Tokyo, and Singapore. The company has established strategic partnerships to enhance its offerings in the competitive AI landscape.

Circles.Life

Venture Round in 2019
Circles.Life is a young, innovative telco, homegrown in Singapore with a mission to re-imagine how mobile services are built and delivered with you in mind. They do this by offering the best no-contract mobile plan, unlimited bonus data and an unparalleled customer experience.

ShopBack

Series B in 2019
ShopBack offers a one-stop lifestyle portal that powers smarter purchase decisions for consumers. Today, ShopBack is the dominant player in Southeast Asia’s e-commerce Cashback market, with an established presence in Singapore, Malaysia, Indonesia, the Philippines, Thailand, and Taiwan, powering over 1,000 orders per hour. ShopBack enhances shopping by providing up to 30% Cashback for consumers to boost their purchasing power while providing cost-effective marketing solutions for merchant partners. With over 1,300 merchant partners, including Uber, Expedia, and Lazada, ShopBack constantly strives to bring a smarter shopping experience to the consumers. In October 2015, ShopBack was awarded the winner of the Gold award in the Best Start-up (Growth Stage) category and Silver award in the Best Innovative Infocomm Products (Consumers) category at the 7th Singapore Infocomm Technology Federation (SiTF) Awards. This is the local start-up’s maiden voyage in industry awards, pitting against more than 300 nominations for the esteemed titles. The company was recently awarded the Emerging Enterprise Award in September 2016, jointly organized by The Business Times (Singapore) and OCBC Bank, which recognizes outstanding small and medium enterprises (SMEs) in Singapore.

Carro

Series B in 2019
Carro is an automotive marketplace that offers a full-stack service for all aspects of car ownership. It challenges the traditional way of buying and selling of cars through a proprietary pricing algorithm. Carro also provides a range of services that offer everything a car owner needs throughout their car ownership journeys such as an in-house financing solution warranty options and Singapore’s first on-demand roadside recovery platform. The company was founded in 2015 and is headquartered in Singapore.

Zilingo

Series D in 2019
Zilingo was founded in 2015 by Ankiti Bose and Dhruv Kapoor with a vision to use technology to put fair and efficient business within everyone’s reach. Up until now, the fashion industry has favored a select few - if you had social, human and financial capital, you could get anything done. But we believe the future of fashion belongs to everyone. By using smart, technology-led solutions to bridge the gap between creators and producers, we’re re-imagining the fashion industry to make it accessible, connected and transparent for all. Find out more on business.zilingo.com.

Carousell

Series C in 2018
Carousell is a classifieds marketplace that allows people to buy and sell preloved items. It is a Singapore-based consumer-to-consumer marketplace app for iOS and Android. The Carousell marketplace has a diverse range of products across a variety of categories, including cars, lifestyle, gadgets, and fashion accessories. It has been ranked as the top Shopping app in Singapore, Taiwan, Hong Kong, and Australia, and is backed by leading international Venture Capitalists Sequoia Capital, Rakuten Ventures, 500 Startups, Golden Gate Ventures, and QuestVC. Launched in Aug 2012, Carousell began in Singapore and has expanded to 19 cities around the world, spanning 7 countries.

Rotimatic

Series C in 2018
Zimplistic is a kitchen robotics startup founded by husband-wife duo Rishi Israni and Pranoti Nagarkar in 2008. We aspire to help people lead a healthier lifestyle by building intelligent solutions to hard problems. By integrating consumer robotics and Internet of Things (IoT), Zimplistic aims to create enterprising appliances that make healthier eating easier and sustainable. At Zimplistic, our mission is to tackle real-world problems to improve the daily lives of people. This gave rise to Rotimatic, our flagship product. It is the world's first kitchen robot that makes fresh, healthy, homemade rotis with a touch of a button. About Rotimatic - Rotimatic is a roti-making appliance that uses artificial intelligence to make rotis (flatbreads) without the need for human supervision. It is a fully automatic robot that processes all the essential ingredients and produces hot and delicious rotis in under a minute. Rotimatic is a technology marvel, packed with some cutting-edge technology innovated by a talented group of health-conscious people. A complete game changer globally - it is compact, user-friendly, and makes preparing rotis a cakewalk. Since its launch in 2016, Rotimatic has disrupted the kitchen appliances segment by piquing the interest of many. By knocking the hassle out of healthy eating, and helping everyone eat fresh food made at home with handpicked ingredients, we believe that people will eat healthier and live better with Rotimatic. It's become a worldwide kitchen sensation with over 3 million rotis served in thousands of households until June 2017. Rotimatic is available for purchase in Singapore, US, UK, Canada, Australia, and New Zealand. Order now - https://rotimatic.com/order/

Engine Biosciences

Seed Round in 2018
Engine Biosciences is a biotechnology company focused on drug discovery through the application of machine learning to genomics. Based in San Francisco and Singapore, the company has developed a proprietary platform that integrates high-throughput laboratory experimentation with artificial intelligence algorithms to analyze complex biological networks. This approach generates unique data on gene interactions and provides biological insights validated through controlled experiments. By deciphering the intricacies of genetic codes, Engine Biosciences aims to accelerate and reduce the costs of research and development for new medical therapies. The platform supports various applications, including target discovery, drug repositioning, and precision medicine, and is utilized by both the company's internal teams and its partners across a range of disease indications. Founded in 2014, the team includes members from prestigious institutions such as MIT, Harvard, and the Mayo Clinic.

Tessa Therapeutics

Venture Round in 2017
Tessa Therapeutics Pte Ltd. is a biotechnology company focused on developing innovative cancer immunotherapies, specifically targeting solid tumors. Founded in 2011 and based in Singapore, the company specializes in creating virus-specific T cells and CAR T cells aimed at treating lymphoma. By advancing these therapies, Tessa Therapeutics seeks to provide healthcare providers with effective options to improve the lives of cancer patients.

Appier

Series C in 2017
Appier Inc. is a technology company that specializes in artificial intelligence solutions to enhance customer engagement for enterprises. Founded in 2012 and headquartered in Taipei, Taiwan, Appier offers a range of AI-driven products, including Aideal, which aids in accelerating purchase decisions; AIQUA, a platform for proactive customer engagement based on user behavior; AIXON, a data science platform that enriches customer data for better audience insights and predictive modeling; and CrossX, an AI-powered advertising solution designed for optimal campaign performance. The company serves approximately 1,000 global brands and agencies, facilitating real-time bidding, programmatic media buying, and deep learning capabilities to help businesses target and retain customers effectively. Appier operates in 14 markets across Asia, including major cities such as Singapore, Kuala Lumpur, Tokyo, and Sydney.

CXA Group

Series B in 2017
From a modest start in 2013, when they had just three Fortune 500 clients, CXA has grown to become Asia’s leading Insurtech start-up - affirmed by over 600 clients and backed by a group of astute investors who understand the value and transformative potential of CXA’s groundbreaking platform. Employees are now able to proactively manage their health by choosing the best-suited insurance, wellness and disease management offerings while employers are able to view aggregated health and claims analytics of their workforce to prioritise interventions that reduce costs and improve workplace health, productivity and employee engagement.

Knewton

Series F in 2016
Knewton, Inc. is a developer of an online adaptive learning engine that personalizes education for students by providing tailored recommendations on what to study. The platform also equips teachers with analytics to enhance their support for individual students and offers publishers insights to create more effective digital educational products. Knewton's technology serves a range of subjects, including math, economics, and sciences, and is utilized by educational institutions and companies worldwide. In addition to its flagship product, Knewton offers Alta, an integrated adaptive learning courseware for higher education. Founded in 2008 and headquartered in New York, Knewton has expanded its presence internationally with offices in London, Tokyo, Singapore, and Dubai. The company has been recognized for its innovation in education technology, earning accolades such as being named a “Technology Pioneer” by the World Economic Forum.

Smaato

Series E in 2014
Smaato Inc. operates a real-time advertising platform that serves mobile publishers, application developers, and advertisers globally. Founded in 2005 and headquartered in San Francisco, California, with additional offices in Hamburg, Germany; New York; Shanghai; Beijing; and Singapore, Smaato provides an enterprise-grade advertising server known as the SPX platform. This platform facilitates mobile monetization by connecting various demand and supply sources, enabling clients to enhance their effective cost per mille (eCPMs) and optimize their monetization strategies. Smaato's technology allows publishers to deliver tailored and engaging experiences to their audiences while leveraging advanced targeting capabilities and competitive intelligence to maximize revenue potential.

Amaranth Medical

Series B in 2013
Amaranth Medical, Inc., a medical device company, develops and manufactures bioresorbable scaffolds for vascular and nonvascular applications. It offers FORTITUDE, a bioresorbable coronary scaffold that assists the artery during the remodeling process following an interventional procedure. The company was incorporated in 2005 and is based in Mountain View, California. It has research and manufacturing operations in Singapore; and Silicon Valley, California.

Smaato

Series D in 2011
Smaato Inc. operates a real-time advertising platform that serves mobile publishers, application developers, and advertisers globally. Founded in 2005 and headquartered in San Francisco, California, with additional offices in Hamburg, Germany; New York; Shanghai; Beijing; and Singapore, Smaato provides an enterprise-grade advertising server known as the SPX platform. This platform facilitates mobile monetization by connecting various demand and supply sources, enabling clients to enhance their effective cost per mille (eCPMs) and optimize their monetization strategies. Smaato's technology allows publishers to deliver tailored and engaging experiences to their audiences while leveraging advanced targeting capabilities and competitive intelligence to maximize revenue potential.

Crisp Mobile

Series C in 2011
A pioneer, innovator and leader in mobile ad technology for more than a decade, Crisp's mission is to help brands activate customers to point-of-purchase experiences through mobile devices. Crisp provides the first end-to-end mobile customer activation platform, Crisp MoCA, that delivers a fully turnkey solution to dominate today and tomorrow's primary point of purchase. Crisp's mature, vertically integrated ad technology and industry-leading product, engineering and operations teams have made it the platform provider of choice for leading CPG's and retailers. Crisp is a privately held company headquartered in New York with offices in Singapore.

Smaato

Series C in 2011
Smaato Inc. operates a real-time advertising platform that serves mobile publishers, application developers, and advertisers globally. Founded in 2005 and headquartered in San Francisco, California, with additional offices in Hamburg, Germany; New York; Shanghai; Beijing; and Singapore, Smaato provides an enterprise-grade advertising server known as the SPX platform. This platform facilitates mobile monetization by connecting various demand and supply sources, enabling clients to enhance their effective cost per mille (eCPMs) and optimize their monetization strategies. Smaato's technology allows publishers to deliver tailored and engaging experiences to their audiences while leveraging advanced targeting capabilities and competitive intelligence to maximize revenue potential.

MerLion Pharma

Series C in 2010
MerLion Pharmaceuticals GmbH a pharmaceutical company, develops antibacterial drugs and biological products. The company offers finafloxacin, a fluoroquinolone antibiotic for the treatment of infection. The company was founded in 2008 and is based in Berlin, Germany. As of August 21, 2006, MerLion Pharmaceuticals GmbH operates as a subsidiary of MerLion Pharmaceuticals Pte. Ltd.

S*Bio

Venture Round in 2008
S*BIO Pte, Ltd., a biotech company, focuses on the discovery and clinical development of novel targeted small drugs for the treatment of cancer. It serves the biotechnology industry in Singapore. The company was founded in 2000 and is based in Singapore, Singapore. S*BIO Pte, Ltd. operates as a subsidiary of Chiron Corporation Limited.

Amaranth Medical

Series A in 2006
Amaranth Medical, Inc., a medical device company, develops and manufactures bioresorbable scaffolds for vascular and nonvascular applications. It offers FORTITUDE, a bioresorbable coronary scaffold that assists the artery during the remodeling process following an interventional procedure. The company was incorporated in 2005 and is based in Mountain View, California. It has research and manufacturing operations in Singapore; and Silicon Valley, California.

Amaranth Medical

Seed Round in 2005
Amaranth Medical, Inc., a medical device company, develops and manufactures bioresorbable scaffolds for vascular and nonvascular applications. It offers FORTITUDE, a bioresorbable coronary scaffold that assists the artery during the remodeling process following an interventional procedure. The company was incorporated in 2005 and is based in Mountain View, California. It has research and manufacturing operations in Singapore; and Silicon Valley, California.

MerLion Pharma

Series A in 2002
MerLion Pharmaceuticals GmbH a pharmaceutical company, develops antibacterial drugs and biological products. The company offers finafloxacin, a fluoroquinolone antibiotic for the treatment of infection. The company was founded in 2008 and is based in Berlin, Germany. As of August 21, 2006, MerLion Pharmaceuticals GmbH operates as a subsidiary of MerLion Pharmaceuticals Pte. Ltd.